Tag: precision oncology
AI model predicts immunotherapy response across cancer types
COMPASS, a pan-cancer foundation model, outperforms 22 methods across 16 clinical cohorts by analyzing tumor transcriptomes through immune concepts.
AdvanCell raises $315 million for AI-driven radiotherapy
The Series D funds targeted alpha therapy for solid tumors using AI-powered isotope targeting.